TacticScaleWhat Encompass Health Does & How It Makes Money (EHC)
Updated October 2026 · reflects Encompass Health's latest reported financials
U.S. operator of inpatient rehabilitation hospitals. It earns patient-service revenue from treating patients in its rehabilitation hospitals.
How Encompass Health makes money
It earns patient-service revenue from treating patients in its rehabilitation hospitals. Payment comes mainly from the federal Medicare program, as well as managed care plans, private insurers, state governments and patients themselves.
What Encompass Health does
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. It serves patients who need intensive, hospital-based rehabilitation after a major injury or illness. Its hospitals provide medical, nursing, therapy and ancillary services for conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. Medicare is the company's main payer, and it also collects from managed care plans, private insurers, state governments and patients. That makes government reimbursement policy an important factor for the business. The company was incorporated in 1984 as HealthSouth Corporation, took the name Encompass Health in January 2018, and is based in Birmingham, Alabama.
Products & services
- Inpatient rehabilitation hospitals
- Stroke and neurological rehabilitation
- Brain and spinal cord injury rehabilitation
- Cardiac and pulmonary rehabilitation
- Complex orthopedic and amputation rehabilitation
- Medical, nursing, therapy and ancillary services
What is Encompass Health worth?
On an owner-earnings DCF, Encompass Health's most-likely value is about $100 versus a recent price near $123 (19% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$43) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
⚠ High leverage — net debt is 6.6× annual cash flow. Net debt is subtracted from this fair value, but refinancing at higher rates, principal timing, and share dilution aren’t modeled — the equity can be worth far less if cash flow weakens.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
The Ensign (ENSG) · HCA Healthcare (HCA) · National HealthCare (NHC) · Universal Health Services (UHS) · Option Care Health (OPCH)